Servier
Clinical trials sponsored by Servier, explained in plain language.
-
Can a menin-blocking drug outsmart stubborn leukemia?
Disease control Not yet recruitingThis trial is testing an experimental drug called S243249, which blocks a protein called menin, in people whose acute leukemia has come back or not responded to standard treatment. The study focuses on patients with specific genetic changes (KMT2A or NUP98 translocations, or NPM1…
Phase: PHASE1, PHASE2 • Sponsor: Servier • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a new pill take on Hard-to-Treat leukemia?
Disease control Not yet recruitingThis early-phase trial is testing an experimental drug called S241656, taken as a tablet, in people with relapsed or refractory acute myeloid leukemia (AML) and related blood cancers. The study aims to find a safe dose and see how the drug behaves in the body, both alone and when…
Phase: PHASE1, PHASE2 • Sponsor: Servier • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC